Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
TThis is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Leveraging A Partner Research Organization In Response To A Global Health Emergency
COVID-19 has highlighted the critical importance of an organized, effective and timely response to a global health emergency.
This webinar explores our learnings from the COVID-19 crisis and how these can be applied to the current development process for drugs, including how to accelerate this process without compromising on critical parameters such as manufacturability, safety and efficacy.
From these learnings, we will identify the key ingredients for fast, effective drug development and how Abzena, as a Partner Research Organization, leverages these in its approach to customer relationships, drug development and manufacturing.
Chief Scientific Officer
Dr. Bunce has over 19 years’ experience working in the biotech and diagnostics sectors, occupying senior management positions within Piramed Pharma (Director, Development Programmes), Immune Targeting Systems (R & D Director) and Oxford Immunotec (General Manager, Immunology Products). He has extensive experience in developing novel biologics and vaccines for cancer, inflammatory and infectious diseases, leading them through development and regulatory processes including pre-clinical evaluation and translation in the clinic.
Campbell has a PhD in Immunology from the University of Manchester and has published a number of papers in T cell biology, immunomodulators and vaccines.
SVP & Head of Scientific Project Leaders
Louise is responsible for providing technical and CMC regulatory leadership and guidance across the Abzena portfolio from Early Development to Commercial production. She is responsible for ensuring scientific input is provided to project teams and works collaboratively with clients for project success. Louise serves as a principle point for contact for clients.
Louise has a very extensive background in the global Bio/pharmaceutical industry with more than 30 years of experience in R&D and Commercial Supply having held senior roles in GlaxoSmithKline as VP & Global Supply Chain Head, Biopharmaceuticals and Janssen R&D (J&J) as VP & Global Head, Strategic Sciences. She has wide-ranging experience in developing, licensing, and supplying Biopharmaceuticals, Vaccines, Cell and Gene Therapy products for global markets. Louise joined Abzena in 2020 as SVP & Head of Scientific Project Leaders
Louise expertise is in the development, technology transfer, and supply of biopharmaceuticals, vaccines, and cell & gene therapies. She has in-depth CMC and Regulatory experience including the development of strategic CMC plans to support regulatory filings such as INDs, IMPDs, BLA, MAAs
Custom Content Writer
Informa Pharma Intelligence